# E. William St. Clair

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/e-william-st-clair/

## Facts

| Field | Value |
| --- | --- |
| Citations | 33,596 |
| Field | Vasculitis and related conditions |
| h-index | 73 |
| i10-index | 169 |
| Last Known Institution | Duke University |
| OpenAlex ID | https://openalex.org/A5013156684 |
| ORCID iD | https://orcid.org/0000-0003-1181-0650 |
| Works | 260 |

## Researcher papers

- [Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/infliximab-and-methotrexate-in-the-treatment-of-rheumatoid-arthritis/)
- [2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/2015-american-college-of-rheumatology-guideline-for-the-treatment-of-rheumatoid/)
- [Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis](https://scholariq.org/papers/rituximab-versus-cyclophosphamide-for-anca-associated-vasculitis/)
- [Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial](https://scholariq.org/papers/infliximab-chimeric-anti-tumour-necrosis-factor-monoclonal-antibody-versus/)
- [2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/2015-american-college-of-rheumatology-guideline-for-the-treatment-of-rheumatoid-2/)
- [Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis](https://scholariq.org/papers/efficacy-of-remission-induction-regimens-for-anca-associated-vasculitis/)
- [Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma](https://scholariq.org/papers/myeloablative-autologous-stem-cell-transplantation-for-severe-scleroderma/)
- [A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score](https://scholariq.org/papers/a-disease-specific-activity-index-for-wegener-s-granulomatosis-modification-of/)

## Researcher topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions-2/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

## Researcher university

- [Duke University](https://scholariq.org/institutions/duke-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.